Consolidated Statements of Cash Flows - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Operating Activities
Net income	$ 11,696	$ 40,005	$ 52,681
Adjustments to reconcile net income to net cash provided (used) by operating activities
Deferred income taxes	893	913	2,786
Provision for credit losses	2,057		(3,500)
Depreciation and amortization	8,525	8,467	8,868
Amortization and accretion of premiums/discounts on investment securities	2,047	3,387	3,744
Amortization of operating lease right-of-use assets	(15)	(229)	(58)
Share-based compensation expense	1,628	1,904	3,095
Originations on loans held for sale	(296,831)	(604,763)	(1,592,108)
Proceeds on loans held for sale	302,252	653,302	1,716,053
(Increase) in value of bank-owned life insurance	(877)	(835)	(793)
Realized loss (gain) on derivative instruments	365	2,006	8,459
Realized loss (gain) on loans sold	(7,323)	(11,616)	(48,038)
Realized loss (gain) on sale of foreclosed assets	(17)	71	(275)
Realized loss (gain) on sale of investment securities	24,643		(125)
Realized loss (gain) on BOLI mortality	(1,196)
Realized loss (gain) on servicing rights	(3)	(702)	(638)
Realized loss (gain) on sale of ESOP trustee line of business	(2,775)
Net change in:
Accrued interest receivable	(2,831)	(3,241)	1,125
Other assets	(5,528)	5,324	(7,309)
Accrued expenses and other liabilities	(7,728)	8,973	5,865
Net cash provided (used) by operating activities	28,982	102,966	149,832
Investing Activities
Proceeds from sales or calls of investment securities available-for-sale	171,758		13,189
Proceeds from maturities of investment securities available-for-sale	67,346	105,633	125,581
Purchases of investment securities available-for-sale		(95,600)	(571,595)
Proceeds from calls of investment securities held-to-maturity	242	963	1,772
Proceeds from maturities and paydowns of investment securities held-to-maturity	20,623	27,429	12,545
Purchases of investment securities held-to-maturity			(218,363)
Net (increase) decrease in loans	(314,718)	(416,150)	221,006
Net (increase) decrease in FHLB stock	2,796	(15,556)	(716)
Net cash received (paid) for business combinations		101,511
Proceeds from BOLI mortality claim	2,828
Purchases of premises and equipment	(3,173)	(1,789)	(1,706)
Proceeds from sales of foreclosed assets	210	937	629
Net cash provided (used) by investing activities	(52,088)	(292,622)	(417,658)
Financing Activities
Net increase (decrease) in deposits	180,127	(358,752)	348,558
Net increase (decrease) in short-term borrowings	(63,910)	378,080
Repayments of long-term debt		(203)	(49,920)
Proceeds from the issuance of subordinated debt			50,000
Cash dividends paid on common stock	(14,822)	(12,800)	(10,751)
Repurchase of common stock	(6,638)	(738)	(712)
Net cash provided (used) by financing activities	94,757	5,587	337,175
Net change in cash and cash equivalents	71,651	(184,069)	69,349
Cash and cash equivalents at beginning of period	58,242	242,311	172,962
Cash and cash equivalents at end of period	129,893	58,242	242,311
Supplemental Cash Flow Disclosures
Interest paid	72,644	15,095	4,538
Income taxes paid	10,840	12,531	13,124
Cash dividends declared, not paid	3,757	3,615	2,776
Cash and cash equivalents acquired		101,696
Supplemental Disclosures of Noncash Investing and Financing Activities
Loan collateral transferred to foreclosed assets	(195)	153	1,176
Investment securities transferred to held-to-maturity			149,191
Right-of-use assets obtained in exchange for new operating lease liabilities, net	1,868	4,266	$ 267
Change in fair value hedges presented within residential real estate loans and other liabilities	$ (166)
Noncash assets acquired		297,745
Liabilities assumed		(354,358)
Issuance of common stock for the acquisition of Metro Phoenix Bank		(64,019)
Net noncash acquired		$ (120,632)